August 15, 2016
Verisk Health Names Dr. Emad Rizk CEO and Board Director
Verisk Health, a leader in data-driven healthcare solutions, today announced that Dr. Emad Rizk has been named Chief Executive Officer (CEO).
August 01, 2016
ECN Acquires MIR3, Extends SaaS-Based Unified Critical Communications Platform to Enterprise Clients
Emergency Communications Network (ECN) has acquired MIR3, a global Software as a Service (SaaS) provider of intelligent communications to business and government clients. The combination of ECN's critical communications platform and MIR3's growing enterprise platform brings together two highly complementary companies, creating an organization uniquely qualified to meet the fast growing demand for software communications solutions.
June 01, 2016
Verisk Analytics, Inc., Announces Closing of Healthcare Services Business Sale
Verisk Analytics, Inc. (Nasdaq:VRSK), a leading data analytics provider, announced the closing of the sale of its healthcare services business to Veritas Capital. The terms of the sale were as previously announced.
April 25, 2016
Verisk Analytics, Inc., Signs Definitive Agreement to Sell Its Healthcare Services Business to Veritas Capital for $820 Million
Verisk Analytics, Inc. (Nasdaq:VRSK), a leading data analytics provider, and Veritas Capital, a leading private equity firm, today announced the signing of a definitive agreement under which an affiliate of Veritas Capital has agreed to acquire Verisk's healthcare services business, Verisk Health, for $820 million.
February 18, 2016
IBM Watson Health Announces Plans to Acquire Truven Health Analytics for $2.6B, Extending Its Leadership in Value-Based Care Solutions
IBM (NYSE: IBM) Watson Health today announced plans to acquire Truven Health Analytics, a leading provider of cloud-based healthcare data, analytics and insights for $2.6 billion. Truven will bring more than 8,500 clients, including U.S. federal and state government agencies, employers, health plans, hospitals, clinicians and life sciences companies to the IBM Watson Health portfolio.